Log on / register
BioMed Central home | Journals A-Z | Feedback | Support | My details
.refereed research
 |  |  |  |  | 


Open AccessHighly AccessMethod

De novo genome sequence assembly of a filamentous fungus using Sanger, 454 and Illumina sequence data

Scott DiGuistini1* email, Nancy Y Liao2* email, Darren Platt3 email, Gordon Robertson2 email, Michael Seidel2 email, Simon K Chan2 email, T Roderick Docking2 email, Inanc Birol2 email, Robert A Holt2 email, Martin Hirst2 email, Elaine Mardis4 email, Marco A Marra2 email, Richard C Hamelin5 email, Jörg Bohlmann6 email, Colette Breuil1 email and Steven JM Jones2 email

Department of Wood Science, University of British Columbia, Vancouver, BC, V6T 1Z4, Canada

BC Cancer Agency Genome Sciences Centre, Vancouver, BC, V5Z 4E6, Canada

Amyris Biotechnologies, Inc., Hollis Street, Emeryville, CA 94608, USA

Washington University School of Medicine, Forest Park Ave, St Louis, MO 63108, USA

Natural Resources Canada, rue du PEPS, Ste-Foy, Quebec, G1V 4C7, Canada

Michael Smith Laboratories, University of British Columbia, Vancouver, BC, V6T 1Z3, Canada

author email corresponding author email* Contributed equally

Genome Biology 2009, 10:R94doi:10.1186/gb-2009-10-9-r94

Published: 11 September 2009

Subject areas: Bioinformatics, Genome studies, Methods

Abstract

Sequencing-by-synthesis technologies can reduce the cost of generating de novo genome assemblies. We report a method for assembling draft genome sequences of eukaryotic organisms that integrates sequence information from different sources, and demonstrate its effectiveness by assembling an approximately 32.5 Mb draft genome sequence for the forest pathogen Grosmannia clavigera, an ascomycete fungus. We also developed a method for assessing draft assemblies using Illumina paired end read data and demonstrate how we are using it to guide future sequence finishing. Our results demonstrate that eukaryotic genome sequences can be accurately assembled by combining Illumina, 454 and Sanger sequence data.


© 1999-2010 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.